Global Medical REIT Inc. (GMRE) Two-Stage Excess Return Model - Discounting Cash Flows
Global Medical REIT Inc.
GMRE (NYSE)

Estimated Value

USD

Market Price 6.61 USD

+
* Values are not guaranteed, please do your own
research before making investment decisions.

#Two-Stage Excess Return Model

Used to estimate the value of companies based on two stages of growth. An initial period of high growth, represented by [Sum of discounted excess returns in Growth Stage], followed by a period of stable growth, represented by [Discounted excess return in terminal stage]. Excess Return models are better suited to calculate the intrinsic value of a financial company than an enterprise valuation model (such as the Discounted Free Cash Flow Model).

Read more: GitHub Documentation

Interactive Assumptions

Results

Estimated Value 27.85 Bil. USD
Book value of equity invested 7.74 USD
Sum of discounted excess returns in Growth Stage 1.43 Bil. USD
Terminal stage EPS 2.4 Bil. USD
Terminal stage Book Value 585.1 Mil. USD
Terminal stage Equity Cost 58.44 Mil. USD
Discounted excess return in terminal stage 26.42 Bil. USD
Excess Returns in the Terminal Stage 42.52 Bil. USD
Terminal Cost of Equity (the discount rate) 9.99%
Terminal year's excess return 2.34 Bil. USD
Average historical Return on Equity 410.3%
Average historical Payout Ratio -4,855%
Payout Ratio in stable stage 98.91%
Yield of the U.S. 10 Year Treasury Bond 4.48%

Historical and Forecasted Data

In USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Beginning Book Value 8.9 8.1 8.1 1325 163075 13429588 559993271
Ending Book Value 8.1 7.74 1325 163075 13429588 559993271 585080969
EPS 0.1 0.052 33.24 5439 669097 55101603 2297652392
Return on Equity 1.14% 1.21% 410.3% 410.3% 410.3% 410.3% 410.3%
Dividend per Share 0.84 0.84 -1284 -156309 -12597416 -491462079 2272564693
Payout Ratio 840% 1,615% -3,864% -2,874% -1,883% -891.9% 98.91%
Retained Earnings -0.74 -0.788 1317 161749 13266513 546563682 25087698
Equity Cost 0.889 0.809 0.809 132.4 16287 1341347 55932127
Cost of Equity 9.99% 9.99% 9.99% 9.99% 9.99% 9.99% 9.99%
Excess Return -0.789 -0.757 32.43 5307 652809 53760255 2241720264
Discounted Excess Return
29.48 4387 490625 36735005 1392691396

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Net Income 0.279 6.49 6.63 20.61 -5.23 -2.07 -20.61 -8.24 13.49 -0.038 -6.35 -1.61
Total Stockholders Equity 403.3 517.4 534.1 583.6 633 622.8 444.8 430.3 269.3 246.3 155 -0.139
Return on Equity 410.3% 1.21% 1.14% 3.26% -0.84% -0.466% -4.79% -3.06% 5.48% -0.025% 4,584% -72.45%
Dividends Paid to Common Shareholders 42.31 56.17 55.39 55.06 54.99 61.85 37 27.09 17.58 15.69
Payout Ratio -4,675% 1,615% 840% 365.2% -1,050% -2,982% -177.8% -333.3% 131.1% -42,110% -3,864% -3,864%
Shares Outstanding 41.43 66.87 65.94 65.55 65.46 60.64 46.26 33.87 21.97 19.62 9.3 0.25
Earnings per Share -0.63 0.052 0.1 0.23 -0.08 -0.034 -0.45 -0.24 0.61 -0.002 -0.68 -6.44
Dividend per Share 0.842 0.84 0.84 0.84 0.84 1.02 0.8 0.8 0.8 0.8
Dividend Growth Rate 4.92% 0% 0% 0% -17.65% 27.5% 0% 0% 0%
Book Value 9.81 7.74 8.1 8.9 9.67 10.27 9.62 12.71 12.26 12.56 16.67 -0.554
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us